| - GRCh37:
- Chr3:150645752
- GRCh38:
- Chr3:150927965
| CLRN1 | T224A, T237A | not provided | Uncertain significance
(Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690438
- GRCh38:
- Chr3:150972651
| CLRN1 | C20R | not provided | Uncertain significance
(Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690456
- GRCh38:
- Chr3:150972669
| CLRN1 | G14R | not provided | Uncertain significance
(Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150659402
- GRCh38:
- Chr3:150941615
| CLRN1 | P134S, P58S | not provided | Uncertain significance
(Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659550
- GRCh38:
- Chr3:150941763
| CLRN1 | | Usher syndrome type 3 | Pathogenic
(Dec 10, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr3:150645425
- GRCh38:
- Chr3:150927638
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690724
- GRCh38:
- Chr3:150972937
| CLRN1, CLRN1-AS1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690681
- GRCh38:
- Chr3:150972894
| CLRN1, CLRN1-AS1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690636
- GRCh38:
- Chr3:150972849
| CLRN1, CLRN1-AS1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690586
- GRCh38:
- Chr3:150972799
| CLRN1, CLRN1-AS1 | | Usher syndrome type 3 | Uncertain significance
(Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645186
- GRCh38:
- Chr3:150927399
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645131
- GRCh38:
- Chr3:150927344
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644908
- GRCh38:
- Chr3:150927121
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644888
- GRCh38:
- Chr3:150927101
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644696
- GRCh38:
- Chr3:150926909
| CLRN1 | | Usher syndrome type 3, not provided | Likely benign
(Jul 12, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690311
- GRCh38:
- Chr3:150972524
| CLRN1 | Q62R | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150659391
- GRCh38:
- Chr3:150941604
| CLRN1 | | Usher syndrome type 3, not provided | Conflicting interpretations of pathogenicity
(Jan 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150645991
- GRCh38:
- Chr3:150928204
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644691
- GRCh38:
- Chr3:150926904
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644542
- GRCh38:
- Chr3:150926755
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644532
- GRCh38:
- Chr3:150926745
| CLRN1 | | not provided, Usher syndrome type 3 | Likely benign
(Sep 25, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150644461
- GRCh38:
- Chr3:150926674
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645920
- GRCh38:
- Chr3:150928133
| CLRN1 | I181F, I168F, I92F | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645714
- GRCh38:
- Chr3:150927927
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645630
- GRCh38:
- Chr3:150927843
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645474
- GRCh38:
- Chr3:150927687
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645985
- GRCh38:
- Chr3:150928198
| CLRN1 | S159F, S70F, S146F | not provided | Uncertain significance
(Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690430
- GRCh38:
- Chr3:150972643
| CLRN1 | | not provided | Likely benign
(Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150659444-150659453
- GRCh38:
- Chr3:150941657-150941666
| CLRN1 | A117fs, A41fs, S174fs | Usher syndrome type 3 | Pathogenic
(Jun 23, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr3:150645985
- GRCh38:
- Chr3:150928198
| CLRN1 | S146Y, S159Y, S70Y | Usher syndrome type 3 | Likely pathogenic
(Jun 23, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr3:150690431
- GRCh38:
- Chr3:150972644
| CLRN1 | L22H | Usher syndrome type 3 | Pathogenic
(Feb 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690368
- GRCh38:
- Chr3:150972581
| CLRN1 | G43V | Usher syndrome type 3, not provided | Pathogenic/Likely pathogenic
(Sep 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645882
- GRCh38:
- Chr3:150928095
| CLRN1 | | not provided | Likely benign
(Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690476
- GRCh38:
- Chr3:150972689
| CLRN1, CLRN1-AS1 | K7I | not provided, Usher syndrome type 3 | Conflicting interpretations of pathogenicity
(Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150659368
- GRCh38:
- Chr3:150941581
| CLRN1 | | Usher syndrome type 3, not provided | Pathogenic
(Sep 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659479
- GRCh38:
- Chr3:150941692
| CLRN1 | L108P, L32P | Usher syndrome type 3 | Pathogenic
(Mar 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690453
- GRCh38:
- Chr3:150972666
| CLRN1 | V15M | not provided | Uncertain significance
(Jan 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690287
- GRCh38:
- Chr3:150972500
| CLRN1 | G70D | Usher syndrome type 3 | Uncertain significance
(Mar 22, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:150690456
- GRCh38:
- Chr3:150972669
| CLRN1 | G14* | Usher syndrome type 3 | Likely pathogenic
(May 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150659430
- GRCh38:
- Chr3:150941643
| CLRN1 | F48fs, W182fs, F124fs | Usher syndrome type 3 | Likely pathogenic
(Mar 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690312
- GRCh38:
- Chr3:150972525
| CLRN1 | Q62* | Usher syndrome type 3 | Likely pathogenic
(Mar 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150658267
- GRCh38:
- Chr3:150940480
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Feb 5, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150659511
- GRCh38:
- Chr3:150941724
| CLRN1 | P155S | not provided, Usher syndrome type 3 | Conflicting interpretations of pathogenicity
(Jan 13, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150659395
- GRCh38:
- Chr3:150941608
| CLRN1 | G136E, G60E | Usher syndrome type 3A, not provided | Uncertain significance
(Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645964-150645966
- GRCh38:
- Chr3:150928177-150928179
| CLRN1 | M76del, M165del, M152del | Usher syndrome type 3 | Uncertain significance
(Jan 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690342-150690345
- GRCh38:
- Chr3:150972555-150972558
| CLRN1 | G51fs | Usher syndrome type 3 | Likely pathogenic
(Dec 21, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150661630
- GRCh38:
- Chr3:150943843
| CLRN1 | M1R, H134Q | Usher syndrome type 3 | Likely benign
(Dec 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150661629
- GRCh38:
- Chr3:150943842
| CLRN1 | M1I, A135T | Usher syndrome type 3 | Uncertain significance
(Dec 4, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690494
- GRCh38:
- Chr3:150972707
| CLRN1, CLRN1-AS1 | M1T | Usher syndrome type 3, Hearing impairment | Likely pathogenic
(Apr 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150661733-150661734
- GRCh38:
- Chr3:150943946-150943947
| CLRN1 | H100fs | Usher syndrome type 3 | Uncertain significance
(Nov 10, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150661663
- GRCh38:
- Chr3:150943876
| CLRN1 | G124fs | Usher syndrome type 3 | Uncertain significance
(Sep 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150661605
- GRCh38:
- Chr3:150943818
| CLRN1 | | Usher syndrome type 3 | Likely benign
(Aug 22, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150661659
- GRCh38:
- Chr3:150943872
| CLRN1 | C125fs | Usher syndrome type 3 | Likely benign
(Aug 2, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690493
- GRCh38:
- Chr3:150972706
| CLRN1, CLRN1-AS1 | M1I | Usher syndrome type 3 | Likely pathogenic
(Jul 17, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150659466
- GRCh38:
- Chr3:150941679
| CLRN1 | H170D | not provided, Usher syndrome type 3 | Likely benign
(Apr 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150658272-150658273
- GRCh38:
- Chr3:150940485-150940486
| CLRN1 | Q157fs | Usher syndrome type 3 | Uncertain significance
(Jul 7, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150661680
- GRCh38:
- Chr3:150943893
| CLRN1 | R118* | Usher syndrome type 3 | Likely benign
(Jun 13, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645881
- GRCh38:
- Chr3:150928094
| CLRN1 | Q194*, Q181*, Q105* | Usher syndrome type 3 | Likely pathogenic
(May 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150661634-150661647
- GRCh38:
- Chr3:150943847-150943860
| CLRN1 | V129fs | Usher syndrome type 3 | Uncertain significance
(Feb 17, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690278
- GRCh38:
- Chr3:150972491
| CLRN1 | Q73R | Usher syndrome type 3, not specified, not provided,
Retinitis pigmentosa, Retinitis pigmentosa 61, Usher syndrome type 3A
| Uncertain significance
(Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690313
- GRCh38:
- Chr3:150972526
| CLRN1 | M61I | Usher syndrome type 3A, Inborn genetic diseases, not provided,
Usher syndrome type 3 | Uncertain significance
(Feb 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:140056310
- GRCh38:
- Chr5:140676725
| HARS1 | R375C, R346C, R335C, R355C, R261C, R301C, R315C | Inborn genetic diseases, Usher syndrome type 3B, not provided
| Uncertain significance
(Jan 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645803
- GRCh38:
- Chr3:150928016
| CLRN1 | R207*, R220* | not provided, Usher syndrome type 3A, Retinitis pigmentosa 61,
Retinitis pigmentosa, Usher syndrome type 3 | Pathogenic
(Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690483
- GRCh38:
- Chr3:150972696
| CLRN1, CLRN1-AS1 | Q5* | not provided, Usher syndrome type 3 | Pathogenic/Likely pathogenic
(Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659366-150659367
- GRCh38:
- Chr3:150941579-150941580
| CLRN1 | | Usher syndrome type 3 | Likely pathogenic
(Mar 22, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690784
- GRCh38:
- Chr3:150972997
| CLRN1, CLRN1-AS1 | | not provided, Usher syndrome type 3 | Conflicting interpretations of pathogenicity
(Dec 22, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150690769
- GRCh38:
- Chr3:150972982
| CLRN1, CLRN1-AS1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690577
- GRCh38:
- Chr3:150972790
| CLRN1, CLRN1-AS1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690566
- GRCh38:
- Chr3:150972779
| CLRN1, CLRN1-AS1 | | not provided, Usher syndrome type 3 | Benign
(Jun 22, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645949
- GRCh38:
- Chr3:150928162
| CLRN1 | E158G, E171G, E82G | not provided, Usher syndrome type 3 | Uncertain significance
(Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645633
- GRCh38:
- Chr3:150927846
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645608
- GRCh38:
- Chr3:150927821
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645448
- GRCh38:
- Chr3:150927661
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645446
- GRCh38:
- Chr3:150927659
| CLRN1 | | not provided, Usher syndrome type 3 | Likely benign
(Aug 6, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645416
- GRCh38:
- Chr3:150927629
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645408
- GRCh38:
- Chr3:150927621
| CLRN1 | | not provided, Usher syndrome type 3 | Benign
(Aug 10, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645351
- GRCh38:
- Chr3:150927564
| CLRN1 | | Usher syndrome type 3 | Benign
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645298
- GRCh38:
- Chr3:150927511
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644867
- GRCh38:
- Chr3:150927080
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644839
- GRCh38:
- Chr3:150927052
| CLRN1 | | not provided, Usher syndrome type 3 | Benign
(Jun 14, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150644759
- GRCh38:
- Chr3:150926972
| CLRN1 | | not provided, Usher syndrome type 3 | Benign
(Dec 18, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150644685
- GRCh38:
- Chr3:150926898
| CLRN1 | | Usher syndrome type 3, not provided, Usher syndrome type 3A
| Conflicting interpretations of pathogenicity
(Jan 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150644684
- GRCh38:
- Chr3:150926897
| CLRN1 | | not provided, Usher syndrome type 3 | Conflicting interpretations of pathogenicity
(Jul 28, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150644558
- GRCh38:
- Chr3:150926771
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644393
- GRCh38:
- Chr3:150926606
| CLRN1 | | Usher syndrome type 3 | Likely benign
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150644392
- GRCh38:
- Chr3:150926605
| CLRN1 | | Usher syndrome type 3 | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150658308
- GRCh38:
- Chr3:150940521
| CLRN1 | | Retinitis pigmentosa, not provided, not specified,
Usher syndrome type 3, Hearing impairment | Uncertain significance
(Apr 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690270
- GRCh38:
- Chr3:150972483
| CLRN1 | | not specified, not provided | Conflicting interpretations of pathogenicity
(Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150645919-150645920
- GRCh38:
- Chr3:150928132-150928133
| CLRN1 | I92fs, I168fs, I181fs | CLRN1-related condition, Usher syndrome, Retinal dystrophy,
not provided, Retinitis pigmentosa 61, Usher syndrome type 3,
Retinitis pigmentosa 61, Retinitis pigmentosa, Usher syndrome type 3A
| Pathogenic/Likely pathogenic
(Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690344-150690347
- GRCh38:
- Chr3:150972557-150972560
| CLRN1 | S50fs | not provided, Rare genetic deafness, Retinal dystrophy,
Usher syndrome type 3, Retinitis pigmentosa, Retinitis pigmentosa 61,
Usher syndrome type 3A | Pathogenic/Likely pathogenic
(May 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645762
- GRCh38:
- Chr3:150927975
| CLRN1 | | not specified, not provided, Usher syndrome type 3
| Conflicting interpretations of pathogenicity
(Oct 30, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150690490
- GRCh38:
- Chr3:150972703
| CLRN1, CLRN1-AS1 | | not provided, Usher syndrome type 3, not specified
| Benign
(Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690439
- GRCh38:
- Chr3:150972652
| CLRN1 | | Usher syndrome type 3A, not provided, not specified,
Usher syndrome type 3 | Benign
(Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659434
- GRCh38:
- Chr3:150941647
| CLRN1 | A123D, A47D, C180* | Usher syndrome type 3A, Rare genetic deafness, Usher syndrome,
not provided, Usher syndrome type 3 | Pathogenic/Likely pathogenic
(Sep 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659497-150659501
- GRCh38:
- Chr3:150941710-150941714
| CLRN1 | C158fs, V25fs, V101fs | Rare genetic deafness, not provided, Usher syndrome type 3
| Pathogenic/Likely pathogenic
(Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690354
- GRCh38:
- Chr3:150972567
| CLRN1 | N48D | not specified, Retinal dystrophy, not provided
| Conflicting interpretations of pathogenicity
(Jun 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150690378
- GRCh38:
- Chr3:150972591
| CLRN1 | C40G | Usher syndrome, Retinal dystrophy, not provided,
Usher syndrome type 3 | Conflicting interpretations of pathogenicity
(Dec 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150690286-150690308
- GRCh38:
- Chr3:150972499-150972521
| CLRN1 | Y63fs | Usher syndrome type 3 | Pathogenic
(Jun 1, 2002) | no assertion criteria provided |
| - GRCh37:
- Chr3:150690307
- GRCh38:
- Chr3:150972520
| CLRN1 | Y63* | CLRN1-related condition, Usher syndrome type 3A, Rare genetic deafness,
not provided, Usher syndrome type 3 | Pathogenic
(Jun 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645973
- GRCh38:
- Chr3:150928186
| CLRN1 | L150P, L163P, L74P | Usher syndrome type 3 | Pathogenic
(Sep 1, 2002) | no assertion criteria provided |